IPHA - Financial Reports List - Innate Pharma S.A. - IntrinsicAlpha

Innate Pharma S.A. IPHA

Healthcare - Biotechnology - NASDAQ - FR

$ 1.83

-5.67 %

$ 153 M

Market Cap

-4.07

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q2	8-K	2024-06-30	-70.09%	-392.89%	-630.25%
Quarterly Report	Q4	8-K	2023-12-31	667.74%	68.07%	60.29%
Annual Report	FY	10-K	2023-12-31	4.56%	92.36%	-8.74%
Quarterly Report	Q2	8-K	2023-06-30	279.27%	107.24%	80.24%
Quarterly Report	Q4	8-K	2022-12-31	-69.22%	-20.05%	-65.43%
Annual Report	FY	10-K	2022-12-31	309.83%	-67.58%	75.64%
Quarterly Report	Q2	8-K	2022-06-30	12.32%	160.99%	150.01%
Quarterly Report	Q4	8-K	2021-12-31	-83.94%	14.44%	25.46%
Annual Report	FY	10-K	2021-12-31	-82.64%	7.58%	-4432.34%
Quarterly Report	Q2	8-K	2021-06-30	-81.94%	-179.15%	-465.56%

1